Sunday, July 30, 2017 6:57:39 PM
a potential Zafgen 2.0?
Pipeline:
Tesomet - Type 2 diabetes - 23 billion USD (Clinical phase 2)
Tesomet PWS - Prader-Willi syndrome - 2 billion USD only in USA (Clinical phase 2)
Tesofensine - Obesity - 250 million USD only in Mexiko (Clinical phase 3) (Tested in 1300 patients.)
NS2359 - Cocaine addiction - 1,8 billion USD only in USA (Clinical phase 2)
GABA-A a2/a3 program - Neuropathic pain - 6 billion USD (Preclinical research)
Boehringer Ingelheim program - Schizofreni - 4,8 billion USD (Preclinical research)
IK - Inflammation,IBD - 5,9 billion USD (Preclinical research)
Nicotinic a6 program - Parkinson - 2,8 billion USD (Preclinical research)
Proximagen program - Neurological disorders - No data (Preclinical research)
Luc Therapeutic program - Ataxi - Rare disease (Preclinical research)
Approximately 40% of the stocks are own by the board and management.
Current market cap 133 million USD.
Alpha Deal analysis:
https://www.biostock.se/wp-content/uploads/2017/07/Saniona_AB_24072017_24.pdf
http://saniona.com/pipeline/
http://saniona.com/investors/ownership-struture/
What do you guys think?
Recent LRMR News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:09:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:06:02 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:57:52 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:08:46 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 01:55:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 11:06:09 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 09:46:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:03:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:33:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:32:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:08:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:51:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:03:03 AM
- Larimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 Trial • Dow Jones News • 07/25/2023 05:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 11:02:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:15:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:13:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:08:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM